Thyron Pharmaceuticals
Westport, US · Founded 2021 · Delaware corporation
Founders & leadership
SB
Stephen BlochNamed on SEC filing
PF
Paul FonteyneNamed on SEC filing
PF
Peter FarinaNamed on SEC filing
DS
David ScheerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2022
▶$500KraisedMay 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedMay 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen BlochExecutive Officer, Director
- Paul FonteyneExecutive Officer, Director
- Peter FarinaDirector
- David ScheerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Thyron Pharmaceuticals raised?
- Thyron Pharmaceuticals has disclosed $500K raised across 1 round.
- Where is Thyron Pharmaceuticals headquartered?
- Thyron Pharmaceuticals is headquartered in Westport, US.